• Citer

Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets.

par Shewiyo, D.H.;Kaale, E;Ugullum, C;Sigonda, M N;Risha, P G;Dejaegher, Bieke ;Smeyers-Verbeke, Johanna;Vander Heyden, Yvan
Référence Journal of pharmaceutical and biomedical analysis, 54, 3, page (445-450)
Publication Publié, 2011

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets.
Auteur:	Shewiyo, D.H.; Kaale, E; Ugullum, C; Sigonda, M N; Risha, P G; Dejaegher, Bieke; Smeyers-Verbeke, Johanna; Vander Heyden, Yvan
Informations sur la publication:	Journal of pharmaceutical and biomedical analysis, 54, 3, page (445-450)
Statut de publication:	Publié, 2011
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Anti-HIV Agents -- analysis -- chemistry
	Calibration
	Chromatography, Thin Layer
	Densitometry
	Drug Combinations
	Humans
	Lamivudine -- analysis -- chemistry
	Nevirapine -- analysis -- chemistry
	Reproducibility of Results
	Sensitivity and Specificity
	Stavudine -- analysis -- chemistry
	Tablets -- analysis
Langue:	Anglais
Identificateurs:	urn:issn:0731-7085
	info:doi/10.1016/j.jpba.2010.09.009
	info:pii/S0731-7085(10)00522-4
	info:pmid/20943338